Sign in

CIK 0001703647 · Non-accelerated filer<br>Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472324450
Phone
617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$2,161,962
in 6 filings, $2.2M under 10b5-1 plans

Net −$1,277,210. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-11 Dolan Oliver Senior Vice President, Finance Sale 10b5-1 −5 $13.72 $69 16,241
2026-09-09 Dolan Oliver Senior Vice President, Finance Sale 10b5-1 −6 $13.60 $82 16,246
2026-09-08 Dolan Oliver Senior Vice President, Finance Sale 10b5-1 −7,347 $13.51 $99K 16,252
2026-07-15 Dolan Oliver Senior Vice President, Finance Grant or award +5,500 23,599
2026-06-16 Dolan Oliver Senior Vice President, Finance Sale −3,383 $10.83 $37K 18,099
2026-02-02 Dolan Oliver Senior Vice President, Finance Grant or award · Stock Option (Right to Buy) +15,000 15,000
2025-12-15 Dolan Oliver Senior Vice President, Finance Grant or award +21,482 21,482
2025-04-01 Dolan Oliver Senior Vice President, Finance Grant or award · Stock Option (Right to Buy) +20,000 20,000

Page 1 of 1 · 8 trades